Work

Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway

Year: 2019

Type: article

Source: International Journal of Hematology

DOI: 10.1007/s12185-019-02667-1

Authors: Kanae Sakakibara, Takayuki Tsujioka, Jun-ichiro Kida, Nami Kurozumi, Takako Nakahara, Shin-ichiro Suemori, Akira Kitanaka, Yujiro Arao, Kaoru Tohyama

Institutions: Okayama University, Kawasaki University of Medical Welfare, Kawasaki Medical School

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Kawasaki Medical School, Japan Society for the Promotion of Science

Award: Elucidation of the molecular pathogenesis of myeloproliferative neoplasms with CALR mutations for the development of novel therapeutic strategies.

OpenAlex ID: W2946705682

FWCI: 0.73

Cites: 45

Cited by: 8

Related to: 10